Center for Financial Planning’s ADMA Biologics ADMA Stock Holding History

Center for Financial Planning’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.6K	Hold	1,500	–	–	﹤0.01%	475
2026 Q1	$13.5K	Hold	1,500	–	–	﹤0.01%	459
2025 Q4	$27.4K	Hold	1,500	–	–	﹤0.01%	375
2025 Q3	$22K	Buy	+1,500	New	+$25.7K	﹤0.01%	407
2021 Q3	–	Sell	-380	Closed	-$1K	–	488
2021 Q2	$1K	Buy	+380	New	+$669	﹤0.01%	471

Other funds holding ADMA

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Center for Financial Planning's ADMA Position: Q2 2026 in Review

Center for Financial Planning held its ADMA Biologics (ADMA) position steady in Q2 2026 at 1,500 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

Center for Financial Planning first reported a position in ADMA in Q2 2021 and has held it in 5 quarters since. The position peaked at $27.4K in Q4 2025. 62 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Center for Financial Planning held 1,500 shares of ADMA Biologics worth $12.6K as of Q2 2026.
Center for Financial Planning left its ADMA Biologics share count unchanged in Q2 2026.
ADMA Biologics made up ﹤0.01% of Center for Financial Planning's portfolio in Q2 2026, its #475 holding.
Center for Financial Planning first reported a position in ADMA Biologics in Q2 2021 and has held it in 5 quarters since.
Center for Financial Planning's ADMA Biologics position peaked at $27.4K in Q4 2025.
62 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.